News

Dementia associated with Alzheimer’s disease is a progressive neurodegenerative condition characterized by memory loss, cognitive decline, and impaired daily functioning. The growing aging population ...
New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD). In preclinical DMD mouse models, investigators demonstrated ...
Suven Life Sciences today announced that the first patient has been randomized in its Phase-2b clinical trial evaluating ...
A growing number of studies have linked midlife mental health disturbances with the development of dementia, but it’s a ...